effect on performance. Therefore, ranking incentives should be used with care. Inducing group identity discourages sabotage …

version instead. We show that pharmacies' substitution incentives are determined by relative margins and relative patient … coinsurance. In terms of policy implications, our results suggest that pharmacy incentives are crucial for promoting generic sales …

version instead. We show that pharmacies' substitution incentives are determined by relative margins and relative patient … generics and their market shares. In terms of policy implications, our results suggest that pharmacy incentives are crucial for …

version instead. We show that pharmacies' substitution incentives are determined by relative margins and relative patient … coinsurance. In terms of policy implications, our results suggest that pharmacy incentives are crucial for promoting generic sales …

We explore the effects of competitive incentives and of their time horizon on the evolution of both asset prices and …

When the assignment of incentives is uncertain, we study how the regularity and frequency of rewards and risk attitudes … show that less able and more risk averse players are less persistent in effort. Intermittent incentives lead to a greater … persistence of effort, while continuous incentives entail exit as soon as payment stops. Randomness increases both earlier and …

When the assignment of incentives is uncertain, we study how the regularity and frequency of rewards and risk attitudes … show that less able and more risk averse players are less persistent in effort. Intermittent incentives lead to a greater … persistence of effort, while continuous incentives entail exit as soon as payment stops. Randomness increases both earlier and …

Therapeutic reference pricing (TRP) of pharmaceuticals is widely thought to steer drug innovation incentives away from …, TRP reduces innovating firms' incentives for therapeutic differentiation and leads to entry of drugs that are less … innovation incentives. On the other hand, TRP leads to lower health benefits unless incentives for therapeutic differentiation …